Cargando…

Antiviral Therapeutic Approaches for SARS-CoV-2 Infection: A Systematic Review

Due to the lack of an etiologic treatment for SARS-CoV-2 and the difficulties involved in developing new drugs, some drugs already approved for other diseases or with efficacy against SARS and MERS, have been used in patients with COVID-19. This systematic review aims to summarize evidence on the ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gil Martínez, Victoria, Avedillo Salas, Ana, Santander Ballestín, Sonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398077/ https://www.ncbi.nlm.nih.gov/pubmed/34451833 http://dx.doi.org/10.3390/ph14080736

Ejemplares similares

Vitamin Supplementation and Dementia: A Systematic Review
por: Gil Martínez, Victoria, et al.
Publicado: (2022)

The Effects of Vitamin D Supplementation in COVID-19 Patients: A Systematic Review
por: Feiner Solís, Ángela, et al.
Publicado: (2022)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Is Supplementation with Micronutrients Still Necessary during Pregnancy? A Review
por: Santander Ballestín, Sonia, et al.
Publicado: (2021)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

Hepatitis C: A Pharmacological Therapeutic Update
por: Santander Ballestín, Sonia, et al.
Publicado: (2021)

Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection
por: Krishna, Gayathri, et al.
Publicado: (2020)

Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection
por: Goswami, Soumik, et al.
Publicado: (2023)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
por: Essa, Raahilah Zahir, et al.
Publicado: (2022)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
por: Hall, Matthew D, et al.
Publicado: (2021)

Therapeutic approaches for SARS-CoV-2 infection
por: Gupta, Ankur, et al.
Publicado: (2021)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
por: Omolo, Calvin A., et al.
Publicado: (2020)

Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404
por: Fàbrega-Ferrer, Montserrat, et al.
Publicado: (2022)

New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection
por: Bauso, Luana Vittoria, et al.
Publicado: (2021)

Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
por: Grosche, Victória Riquena, et al.
Publicado: (2023)

SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
por: Rebeaud, Mathieu E., et al.
Publicado: (2020)

Host proviral and antiviral factors for SARS-CoV-2
por: Lv, Lu, et al.
Publicado: (2021)

Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
por: Beyer, Daniel K., et al.
Publicado: (2022)

Antiviral Effect of Budesonide against SARS-CoV-2
por: Heinen, Natalie, et al.
Publicado: (2021)

Theory and reality of antivirals against SARS-CoV-2
por: Zhao, Bo, et al.
Publicado: (2021)

Antiviral Efficacy of Pralatrexate against SARS-CoV-2
por: Bae, Joon-Yong, et al.
Publicado: (2021)

What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
por: Martinez, Miguel Angel
Publicado: (2022)

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
por: Ginex, Tiziana, et al.
Publicado: (2021)

Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach
por: Wyman, Kailey A., et al.
Publicado: (2022)

A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics
por: Prathiviraj, R., et al.
Publicado: (2021)

Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target
por: Qin, Bo, et al.
Publicado: (2023)

SARS‐CoV‐2 modulation of RIG‐I‐MAVS signaling: Potential mechanisms of impairment on host antiviral immunity and therapeutic approaches
por: Wang, Mingming, et al.
Publicado: (2022)

Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity
por: Jones, Thane, et al.
Publicado: (2023)

Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies
por: Almagro, Juan C., et al.
Publicado: (2022)

Current status of therapeutic approaches and vaccines for SARS-CoV-2
por: Wahid, Braira, et al.
Publicado: (2021)

Combinatory therapeutic approaches for common cold and SARS-CoV-2
por: Anbalagan, Sankarappan, et al.
Publicado: (2020)

Present therapeutic and diagnostic approaches for SARS-CoV-2 infection
por: Gupta, Sayan Dutta, et al.
Publicado: (2022)

Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
por: Scroggs, Stacey L. P., et al.
Publicado: (2020)

Potential Antiviral Options against SARS-CoV-2 Infection
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a2n6tnsdkh9sg68p6eid76bug7